Thrombosis and Haemostasis, Table of Contents Thromb Haemost 2008; 99(01): 108-115DOI: 10.1160/TH07-08-0490 Platelets and Blood Cells Schattauer GmbH Simulation of platelet adhesion and aggregation regulated by fibrinogen and von Willebrand factor Authors Author Affiliations Daisuke Mori 1 Deptartment of Bioengineering and Robotics, Tohoku University, Japan Koichiro Yano 2 Toyota Motor Corporation, Japan Ken-ichi Tsubota 3 Department of Electronics and Mechanical Engineering, Chiba University, Japan Takuji Ishikawa 1 Deptartment of Bioengineering and Robotics, Tohoku University, Japan Shigeo Wada 4 Department of Mechanical Science and Bioengineering, Osaka University, Japan Takami Yamaguchi 1 Deptartment of Bioengineering and Robotics, Tohoku University, Japan Recommend Article Abstract Full Text PDF Download(opens in new window) Keywords KeywordsComputational simulation - glycoprotein receptors - thrombus - shear flow References References 1 Ruggeri ZM. Platelets in atherothrombosis. Nature Med 2002; 8: 1227-1234. 2 Rao AK, Holmsen H. Congenital disorders of platelet function. Semin Hematol 1986; 23: 102-118. 3 Goto S, Salomon DR, Ikeda Y. et al. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J Biol Chem 1995; 270: 23352-23361. 4 Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289-297. 5 Goto S, Ikeda Y, Saldivar E. et al. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest 1998; 101: 479-486. 6 Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. New Engl J Med 1995; 332: 1553-1559. 7 Ruggeri ZM. Von Willebrand factor and the mechanisms of platelet functions.. Springer-Verlag; : 1998 8 Ruggeri ZM. Platelet interactions with vessel wall components during thrombogenesis. Blood Cells Mol Dis 2006; 36: 145-147. 9 Hennan JK, Swillo RE, Morgan GA. et al. Pharmacologic inhibition of platelet vWF-GPIb alpha interaction prevents coronary artery thrombosis. Thromb Haemost 2006; 95: 469-475. 10 Penz SM, Reininger AJ, Toth O. et al. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques. Thromb Haemost 2007; 97: 435-443. 11 Ruggeri ZM. Von Willebrand factor: looking back and looking forward. Thromb Haemost 2007; 98: 55-62. 12 Wadanoli M, Sako D, Shaw GD. et al. The von Willebrand factor antagonist (GPG-290) prevents coronary thrombosis without prolongation of bleeding time. Thromb Haemost 2007; 98: 397-405. 13 Fogelson AL. Continuum models of platelet-aggregation – Formulation and mechanical-properties. Siam J Appl Math 1992; 52: 1089-1110. 14 Wang NT, Fogelson AL. Computational methods for continuum models of platelet aggregation. J Comp Phys 1999; 151: 649-675. 15 Tamagawa M, Matsuo S. Predictions of thrombus formation using lattice Boltzmann method – (Modeling of adhesion force for particles to wall). Japan Soc Mechan Eng Int J C-Mechanical Systems Machine Elements and Manufacturing 2004; 47: 1027-1034. 16 Kamada H, Tsubota K, Wada S. et al. Computer simulation of formation and collapse of primary thrombus due to platelet aggregation using particle method. Transact Japan Soc Mechan Eng B 2006; 72: 1109-1115. 17 Pivkin IV, Richardson PD, Karniadakis G. Blood flow velocity effects and role of activation delay time on growth and form of platelet thrombi. Proc Natl Acad Sci USA 2006; 103: 17164-17169. 18 Miyazaki H, Yamaguchi T. Formation and destruction of primary thrombi under the influence of blood flow and von Willebrand factor analyzed by a discrete element method. Biorheology 2003; 40: 265-272. 19 Yano K, Mori D, Tsubota K. et al. Analysis of Destruction Process of the Primary Thrombus Under the Influence of the Blood Flow. J Biomech Sci Eng 2007; 2: 34-44. 20 Weiss HJ, Rogers J. Fibrinogen and platelets in the primary arrest of bleeding. Studies in two patients with congenital afibrinogenemia. New Engl J Med 1971; 285: 369-374. 21 Tschopp TB, Weiss HJ, Baumgartner HR. Decreased adhesion of platelets to subendothelium in von Willebrand's disease. J Lab Clin Med 1974; 83: 296-300. 22 Ruggeri ZM. von Willebrand factor and fibrinogen. Curr Opin Cell Biol 1993; 5: 898-906. 23 Satoh A, Chantrell RW, Coverdale GN. et al. Stokesian Dynamics Simulations of Ferromagnetic Colloidal Dispersions in a Simple Shear Flow. J Colloid Interface Sci 1998; 203: 233-248. 24 Satoh A. Comparison of approximations between additivity of velocities and additivity of forces for Stokesian dynamics methods. J Colloid Interface Sci 2001; 243: 342-350. 25 Durlofsky L, Brady JF, Bossis G. Dynamic Simulation of Hydrodynamically Interacting Particles. J Fluid Mech 1987; 180: 21-49. 26 Frojmovic MM, Milton JG. Human platelet size, shape, and related functions in health and disease. Physiol Rev 1982; 62: 185-261. 27 Kim S, Karrila SJ. Microhydrodynamics. Principles and Selected Applications.. Butterworth-Heinemann, Stoneham; : 1991 28 Siedlecki CA, Lestini BJ, Kottke-Marchant KK. et al. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood 1996; 88: 2939-2950.
